---
figid: PMC6585737__GLIA-66-2531-g003
figtitle: Metabolic drugs and molecular pathways exploitable to drive microglia into
  a pro‐regenerative phenotype
organisms:
- NA
pmcid: PMC6585737
filename: GLIA-66-2531-g003.jpg
figlink: /pmc/articles/PMC6585737/figure/glia23484-fig-0003/
number: F3
caption: Metabolic drugs and molecular pathways exploitable to drive microglia into
  a pro‐regenerative phenotype. Dichloroacetate (DCA) promotes glucose metabolism
  in mitochondria by increasing the flux of pyruvate. Dimethylfumarate (DMF) promotes
  an antioxidant response and mitochondrial biogenesis through activation of the Nrf2
  pathway. It may also enhance TCA cycle by increasing the TCA cycle intermediate
  fumarate. Metformin promotes oxidative phosphorylation through AMPK activation.
  Aldose reductase (AR) converts glucose into sorbitol using NADPH as a cofactor.
  Sorbitol, in turn, activates the phospholipase C/protein kinase C signaling pathway,
  resulting in downstream activation of pro‐inflammatory NF‐κB. By inhibiting AR,
  the small‐molecule FMHM, Sorbinil, Zopolrestat, and Fidarestat, limit inflammatory
  microglia response. Furthermore, Fidarestat induces CREB phosphorylation to increase
  Arg1. SIRT1 activators, such as Resveratrol, inhibit the pro‐inflammatory NF‐kB
  pathway and activate fatty acid metabolism. The scheme also depicts how NF‐kB, iNOS,
  and NOX activities are influenced by the bioenergetics state of microglia. NADPH
  generated via glucose metabolism through PPP is a cofactor for the production of
  NO, by iNOS, and of superoxide, by NOX. NADH generated through glycolysis promotes
  dimerization of C‐terminal binding protein (CtBP), preventing the corepressor activity
  of the monomeric form on the p300 acetylase, a NK‐kB activator, with consequent
  activation of NF‐kB transcriptional activity
papertitle: How to reprogram microglia toward beneficial functions.
reftext: Marta Fumagalli, et al. Glia. 2018 Dec;66(12):2531-2549.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9517126
figid_alias: PMC6585737__F3
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC6585737__F3
ndex: d5f9a1b3-def2-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6585737__GLIA-66-2531-g003.html
  '@type': Dataset
  description: Metabolic drugs and molecular pathways exploitable to drive microglia
    into a pro‐regenerative phenotype. Dichloroacetate (DCA) promotes glucose metabolism
    in mitochondria by increasing the flux of pyruvate. Dimethylfumarate (DMF) promotes
    an antioxidant response and mitochondrial biogenesis through activation of the
    Nrf2 pathway. It may also enhance TCA cycle by increasing the TCA cycle intermediate
    fumarate. Metformin promotes oxidative phosphorylation through AMPK activation.
    Aldose reductase (AR) converts glucose into sorbitol using NADPH as a cofactor.
    Sorbitol, in turn, activates the phospholipase C/protein kinase C signaling pathway,
    resulting in downstream activation of pro‐inflammatory NF‐κB. By inhibiting AR,
    the small‐molecule FMHM, Sorbinil, Zopolrestat, and Fidarestat, limit inflammatory
    microglia response. Furthermore, Fidarestat induces CREB phosphorylation to increase
    Arg1. SIRT1 activators, such as Resveratrol, inhibit the pro‐inflammatory NF‐kB
    pathway and activate fatty acid metabolism. The scheme also depicts how NF‐kB,
    iNOS, and NOX activities are influenced by the bioenergetics state of microglia.
    NADPH generated via glucose metabolism through PPP is a cofactor for the production
    of NO, by iNOS, and of superoxide, by NOX. NADH generated through glycolysis promotes
    dimerization of C‐terminal binding protein (CtBP), preventing the corepressor
    activity of the monomeric form on the p300 acetylase, a NK‐kB activator, with
    consequent activation of NF‐kB transcriptional activity
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Eaat1
  - Glut1
  - Glut4EF
  - Glut3
  - smp-30
  - ar
  - G6P
  - norpA
  - sl
  - Plc21C
  - Pdh
  - Pdha
  - Pdf
  - Pdhb
  - Inos
  - Nos
  - CrebB
  - CrebA
  - Nox
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - ac
  - osa
  - nej
  - CycE
  - cyc
  - Argl
  - dac
  - dap
  - alpha-Cat
  - Keap1
  - cnc
  - en
  - ORY
  - Sirt1
  - SNF4Agamma
  - AMPKalpha
  - nos
  - pk
  - Pc
  - CBP
  - eIF4E1
  - CtBP
  - Mos
  - Dd
  - vn
  - SLC2A1
  - HLA-DQA2
  - AR
  - DECR1
  - HSPG2
  - PLCE1
  - PLCZ1
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - PLCD1
  - PLCD3
  - PLCD4
  - PLCG1
  - PLCG2
  - PDP1
  - DLAT
  - DLD
  - PDHA1
  - PDHA2
  - PDHB
  - PDHX
  - NOS2
  - ISYNA1
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - DAO
  - ADCY1
  - ADCY2
  - ADCY3
  - ADCY4
  - ADCY5
  - ADCY6
  - ADCY7
  - ADCY8
  - ADCY9
  - ADCY10
  - EP300
  - CIB1
  - EIF2B5
  - RTRAF
  - ARG1
  - TINAGL1
  - CEBPA
  - CEBPB
  - CEBPD
  - CEBPG
  - CEBPE
  - AADAC
  - FBXW4
  - GABPA
  - NFE2L2
  - CYBA
  - CYBB
  - DUOX1
  - DUOX2
  - NCF1
  - NCF2
  - NCF4
  - NOX1
  - NOX3
  - NOX4
  - NOX5
  - RAC1
  - SIRT1
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - NOS1
  - NOS3
  - GNAS
  - PC
  - CST8
  - CREBBP
  - EIF4E
  - OPN1LW
  - PAG1
  - PCBP4
  - MOS
  - MOCOS
  - KRT5
  - Glucose
  - DCA
  - Sorbinil
  - Sorbitol
  - NADPH
  - Fatty acids
  - Acetyl-CoA
  - NADH
  - FATTY ACID
  - Citrate
  - Aldose
  - Nitric oxide
  - AMP
  - DMF
  - Metformin
  - Glyceraldehyde 3-phosphate
  - Resveratrol
  - 7-phosphate
  - POH Pyruvate
  - POH
---
